Telomir Pharmaceuticals announces passing of CEO Christopher Chapman

Telomir Pharmaceuticals announced the passing of Chairman of the Board and CEO Christopher Chapman, Jr., M.D. Out of respect and privacy for Dr. Chapman’s family, details of his passing will not be made available. Telomir’s Board of Directors has named Erez Aminov, currently Chairman of the Board and CEO of MIRA Pharmaceuticals, Inc. (MIRA), as a director, Chairman of the Board and CEO of Telomir. To offer support to Telomir’s new senior management, three Telomir directors have voluntarily resigned from the Telomir Board of Directors, and three individuals have been appointed as replacements. The new Telomir directors are Dr. Matthew P. Del Giudice, Mr. Ned MacPherson and Matthew Pratt Whalen, CPA. Dr. Craig Eagle and Michael Jerman, each sitting directors of Telomir, will remain on the Telomir Board of Directors. The resigning directors are Hugh McColl III, Talhia Tuck and Brad Kroenig.